About Ddrc Agilus Pathlabs Limited
Data last updated: 16 February 2026
Ddrc Agilus Pathlabs Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Agilus Diagnostics Limited. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 28 April 2006, the company has been in operation for over 20 years.
Registered with ROC Mumbai under CIN U85190MH2006PTC161480.
Capital: an authorised share capital of ₹12.5 Cr and a paid-up capital of ₹50 Lakh. Formerly known as Ddrc Srl Diagnostics Private Limited and Ddrc Piramal Diagnostic Services Private Limited. It is led by directors including Anand Kuppuswamy and Akshay Kumar Tiwari.
Last AGM: 31 July 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹322 Cr, a growth of 15% compared to the previous year.
The company has a workforce of approximately 2,494 employees as per the latest available data. It operates as a subsidiary of Agilus Diagnostics Limited.
As per MCA filings, the company has open charges of ₹45.46 Lakh and satisfied charges of ₹6.94 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website agilusdiagnostics.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Apps
-
Registered Address4Th Floor Prime Square Plot No.1 Gaiwadi Industrial Estate S.V.Road Goreg, Aon (West), Mumbai, Maharashtra, India – 400062
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Ddrc Agilus Pathlabs Limited
Ddrc Agilus Pathlabs Limited has undergone 5 name changes throughout its history. The current legal name is Ddrc Agilus Pathlabs Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Ddrc Agilus Pathlabs Limited | Current |
| Ddrc Srl Diagnostics Private Limited | Previous |
| Ddrc Piramal Diagnostic Services Private Limited | Previous |
| Ddrc Srl Diagnostics Limited | Previous |
| Ddrc Wellspring Private Limited | Previous |
| Ddrc Wellspring Pathlabs Private Limited | Previous |
CIN History of Ddrc Agilus Pathlabs Limited
Ddrc Agilus Pathlabs Limited has one previous CIN (Corporate Identification Number): U85190MH2006PTC161480. The current CIN is U85190MH2006PLC161480, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85190MH2006PLC161480 | Current |
| U85190MH2006PTC161480 | Previous |
Business Activity of Ddrc Agilus Pathlabs Limited
Ddrc Agilus Pathlabs Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | ********* |
Board of Directors of Ddrc Agilus Pathlabs Limited
Ddrc Agilus Pathlabs Limited is currently managed by 3 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Anand Kuppuswamy
Also directs:
Agilus Diagnostics Limited, Agilus Pathlabs Private Limited
|
Director | 11 Aug 2020 | 5 Years 10 Months | Current |
|
Akshay Kumar Tiwari
Also directs:
Agilus Pathlabs Private Limited, Agilus Pathlabs Reach Limited
|
Director | 27 Sep 2024 | 1 Years 9 Months | Current |
| Rashmi Talwar | Director | 06 Jun 2025 | 1 Years 1 Months | Current |
Financials of Ddrc Agilus Pathlabs Limited FY 2025 filings available
Ddrc Agilus Pathlabs Limited reported revenue of ₹322 Cr (up 15% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Ddrc Agilus Pathlabs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2022 | Hdfc Bank Limited | ₹45.46 Lakh | Open |
| 26 Mar 2018 | Hdfc Bank Limited | ₹1.94 Cr | Satisfied |
| 21 Dec 2012 | Hdfc Bank Limited | ₹30 Lakh | Satisfied |
| 21 Dec 2012 | Hdfc Bank Limited | ₹4 Cr | Satisfied |
| 21 Dec 2012 | Hdfc Bank Limited | ₹70 Lakh | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Ddrc Agilus Pathlabs Limited
View historical data on people associated with Ddrc Agilus Pathlabs Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Ddrc Agilus Pathlabs Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Ddrc Agilus Pathlabs Limited
GSTIN & GST Filing Data of Ddrc Agilus Pathlabs Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Ddrc Agilus Pathlabs Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Ddrc Agilus Pathlabs Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Ddrc Agilus Pathlabs Limited
MSME Payment Delays by Ddrc Agilus Pathlabs Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Ddrc Agilus Pathlabs Limited
Subsidiaries & Group Companies of Ddrc Agilus Pathlabs Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ddrc Agilus Pathlabs Limited with ownership details.
MCA Filings & Documents of Ddrc Agilus Pathlabs Limited
MCA Filings & Documents of Ddrc Agilus Pathlabs Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Ddrc Agilus Pathlabs Limited
Frequently Asked Questions about Ddrc Agilus Pathlabs Limited
Ddrc Agilus Pathlabs Limited is an active public limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 28 April 2006 (20+ years old) and is registered under CIN U85190MH2006PLC161480. The company has 2,494 employees.
Ddrc Agilus Pathlabs Limited reported revenue of ₹322 Cr for FY 2025 (up 15.00% YoY).
The current directors of Ddrc Agilus Pathlabs Limited are:
The primary industry of Ddrc Agilus Pathlabs Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Ddrc Agilus Pathlabs Limited can be reached at the registered office: 4Th Floor Prime Square Plot No.1 Gaiwadi Industrial Estate S.V.Road Goreg, Aon West, Mumbai, Maharashtra, India – 400062, or through the website agilusdiagnostics.com.
The authorised capital is ₹12.5 Cr, and the paid-up capital is ₹50 Lakh.